Use Power Terms™ and proper capitalization for best results (view examples)
   
Clear All
   
 
Applied Filters
None
Filters
 
Also Containing
Published Within
Publication Type
»More
 
Key Concepts
  Relationships (185)     Keyword Results (2,940)    
1
Glaxo is partnered on XenoPort's lead program, Horizant, for neuropathic pain and restless leg syndrome.
2
Arbitrator sides with Biogen in Rituxan dispute
FierceMarkets Open HTML    
Maureen Martino
Fierce Biotech (2009) Show Abstract »
Genentech and Biogen Idec are partners on the blockbuster cancer and rheumatoid arthritis drug Rituxan.
3
Does Bayer's Intervet bid signal hunger for deals?
FierceMarkets Open HTML    
Tracy Staton
Fierce Pharma (2009) Show Abstract »
But Schering's merger partner Merck elected to keep Intervet and sell its 50 percent share in Merial to partner Sanofi- Aventis.
Sponsor
4
The race between Merck and Vertex--which is partnered with Johnson & Johnson- -to gain approval of a new hepatitis C therapy is coming down to the wire.
5
Shire and Protalix--which is partnered with Pfizer--are likely to wage a war for market share by lowballing Cerezyme's $200,000 annual price tag.
6
Alkermes readies mid-stage trial in research shift
FierceMarkets Open HTML    
John Carroll
Fierce Biotech (2009) Show Abstract »
Up to now, Cambridge, MA-based Alkermes has been known primarily for the drug delivery technology that it has supplied to partners like Johnson & Johnson and Eli Lilly.
Sponsor
7
Rumors: Glaxo eyes bid for Human Genome Sciences
FierceMarkets Open HTML    
John Carroll
Fierce Biotech (2009) Show Abstract »
In recent weeks, HGS shares have been jazzed by the stunning clinical success of its lupus drug Benlysta, which is partnered with Glaxo.
» More Relationships
8 Full-text article
Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial
BioMed Central Open HTML Open PDF     PubMed Open HTML    
Sydes MR Royston P  » 
Trials (2009) Show Abstract »
The three industry partners for STAMPEDE (Novartis, Sanofi-Aventis and Pfizer) have all been supportive and have provided important input at various stages, including the provision of trial drug and modest educational grants.
9
AZ to pay $647M for Merck rights
FierceMarkets Open HTML    
Tracy Staton
Fierce Pharma (2010) Show Abstract »
AstraZeneca and Merck have been partners on these and other drugs for years; the original sales-and-distribution deal dates to 1982, with a restructuring in 1998.
10
Silence gets green light for siRNA trial
FierceMarkets Open HTML    
John Carroll
Fierce Biotech (2009) Show Abstract »
This is a major step forward." Silence Therapeutics is partnered with Pfizer and AstraZeneca in human trials that put short interfering RNA therapies directly on the treatment site.
Page: 1 2 3 4 519 | Next»